XML 71 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Jun. 30, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 545,288 $ 868,067
Short-term investment 39,329 39,249
Accounts receivable, net 892,556 284,395
Costs and estimated earnings in excess of billings on uncompleted contracts 135,278 36,476
Inventory 256,769 48,011
Prepaid expenses and other current assets 3,493 1,405
Total current assets 1,872,713 1,277,603
Equipment, net 6,968 6,064
Debt issuance costs, net 89,660 103,632
Totals 1,969,341 1,387,299
Current liabilities:    
Accounts payable and accrued expenses 718,688 343,080
Accrued interest, related party 24,504 20,439
Accrued interest 70,704   
Related party accounts payable and accrued expenses 171,469 102,856
Related party notes payable 73,500 73,500
Convertible debentures, net 565,812   
Billings in excess of costs and estimated earnings on uncompleted contracts 62,646 69,789
Deferred revenue 466,967 201,117
Conversion option liabilities 26,699 69,502
Warrant liabilities 281,528 337,055
Total current liabilities 2,462,517 1,217,338
Convertible debentures, net 1,001,355 685,692
Total liabilities 3,463,872 1,903,030
Commitments      
Stockholders' deficiency:    
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 0 issued and outstanding at June 30, 2013 and December 31, 2012      
Common stock, $0.01 par value, 100,000,000 shares authorized; 42,198,093 issued and outstanding at June 30, 2013 and December 31, 2012 421,981 421,981
Additional paid-in capital 6,311,801 6,099,635
Accumulated deficiency (8,224,012) (7,036,776)
Accumulated other comprehensive loss (4,301) (571)
Total stockholders' deficiency (1,494,531) (515,731)
Totals $ 1,969,341 $ 1,387,299